A year before she passed away, actress Michelle Trachtenberg sought to let her supporters know she was in good health.

Taking a mental health leave from work is becoming more of an option for people in the United States even thought most of ...

From her captivating performance in Cruel Intentions to her iconic role in Legally Blonde, Selma Blair cemented herself into ...

Access our full analysis report here, it’s free. Healthcare Technology for Patients company Hims & Hers Health (NYSE:HIMS) fell 10.2%. Is now the time to buy Hims & Hers Health? Access our full ...

Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal health conditions while achieving scalable profitability ...

Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 index. Investor excitement about news of a fresh product launch the previous ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025. However, this sizzling momentum came to a screeching halt in recent weeks. Hims ...

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the ...

The alleged facts of this case — where a mother is accused of intentionally taking the life of her young child — are ...

Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli Lilly And Co's (NYSE:LLY) Zepbound through its Telehealth platform.

Hims & Hers Health, Inc. (HIMS) closed the latest trading day at $27.23, indicating a +1.57% change from the previous session's end. The stock fell short of the S&P 500, which registered a gain of ...

Kimberly Williams-Paisley detailed losing her voice for two years due to a sudden onset of vocal cord paralysis.